Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Clotrimazole
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Clotrimazole 1% cream
1310020H0AAABAB
|
Clotrimazole (Topical) | Clotrimazole | Skin | 151,921 |
|
Clotrimazole 500mg pessary and Clotrimazole 2% cream
0702020F0AAAKAK
|
Clotrimazole (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 101,482 |
|
Clotrimazole 2% cream
0702020F0AAAJAJ
|
Clotrimazole (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 73,443 |
|
Clotrimazole 500mg pessaries
0702020F0AAAFAF
|
Clotrimazole (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 31,628 |
|
Clotrimazole 1% solution
1310020H0AAAAAA
|
Clotrimazole (Topical) | Clotrimazole | Skin | 13,686 |
|
Clotrimazole 200mg pessaries
0702020F0AAAEAE
|
Clotrimazole (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 12,843 |
|
Fluconazole 150mg capsule and Clotrimazole 2% cream
0702020F0AAANAN
|
Clotrimazole (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 11,573 |
|
Canesten Combi 500mg pessary and 2% cream
0702020F0BBAKAK
|
Canesten (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 8,529 |
|
Clotrimazole 10% vaginal cream
0702020F0AAAGAG
|
Clotrimazole (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 5,877 |
|
Canesten 1% cream
1310020H0BBAAAB
|
Canesten (Topical) | Clotrimazole | Skin | 4,438 |
|
Clotrimazole 100mg pessaries
0702020F0AAADAD
|
Clotrimazole (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 3,702 |
|
Clotrimazole 1% spray
1310020H0AAAEAE
|
Clotrimazole (Topical) | Clotrimazole | Skin | 2,744 |
|
Canesten Thrush 500mg pessaries/Canesten 500mg pessaries
0702020F0BBAFAF
|
Canesten (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2,456 |
|
Clotrimazole 10% cream and Clotrimazole 2% cream
0702020F0AAALAL
|
Clotrimazole (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2,393 |
|
Canesten 2% thrush cream
0702020F0BBAJAJ
|
Canesten (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1,085 |
|
Canesten Thrush Duo 150mg Oral capsules & External 2% cream
0702020F0BBAMAN
|
Canesten (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 679 |
|
Canesten 1% solution
1310020H0BBABAA
|
Canesten (Topical) | Clotrimazole | Skin | 604 |
|
Canesten Combi 500mg Soft Gel pessary and External 2% cream
0702020F0BBAQAK
|
Canesten (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 555 |
|
Canesten 10% vaginal cream
0702020F0BBAGAG
|
Canesten (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 314 |
|
Canesten 200mg pessaries
0702020F0BBADAE
|
Canesten (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 269 |
|
Canesten Thrush 500mg Soft Gel pessaries
0702020F0BBARAF
|
Canesten (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 244 |
|
Canesten Combi Pessary & Cream
0702020F0BBANAK
|
Canesten (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 237 |
|
Canesten Thrush Combi 500mg Soft Gel pess & External 2% crm
0702020F0BBATAK
|
Canesten (Vaginal) | Clotrimazole | Obstetrics, Gynaecology and Urinary-Tract Disorders | 189 |
|
Canesten Dermatological 1% spray
1310020H0BBACAE
|
Canesten (Topical) | Clotrimazole | Skin | 121 |
|
Canesten Antifungal cream
1310020H0BBAHAB
|
Canesten (Topical) | Clotrimazole | Skin | 118 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.